The role of Humphrey Matrix testing in the early diagnosis of retinopathy in type 1 diabetes

British Journal of Ophthalmology

Volumn 92, Issue 12, 2008, Pages 1656-1660

  Parravano, M ^a   Oddone, F ^a   Mineo, D ^b   Centofanti, M ^b   Borboni, P ^b   Lauro, R ^b   Tanga, L ^a   Manni, G ^b  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIREFRINGENCE; CLINICAL ARTICLE; CONTROL GROUP; DIABETIC RETINOPATHY; FEMALE; HUMAN; HUMPHREY MATRIX TEST; INSULIN DEPENDENT DIABETES MELLITUS; MALE; METABOLIC REGULATION; PERIMETRY; POLARIMETRY; PRIORITY JOURNAL; RETINA NERVE CELL; SCANNING LASER POLARIMETRY; SCREENING TEST; VISUAL FIELD;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EARLY DIAGNOSIS; FEMALE; HUMANS; INTRAOCULAR PRESSURE; MALE; PERIMETRY; SEVERITY OF ILLNESS INDEX;

EID: 57149118927     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.143057     Document Type: Article

References (25)

1. UKPDS. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-65.
2. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1993;46:271-86.
3. Konigsreuther KA, Jonas JB. Optic disc morphology in diabetes mellitus. Graefes Arch Clin Exp Ophthalmol 1995;233:200-4.
4. Chihara E, Matsuoka T, Ogura Y, et al. Retinal nerve fiber layer defect as an early manifestation of diabetic retinopathy. Ophthalmology 1993;100:431-35.
5. Fletcher EL, Phipps JA, Wilkinson-Berka JL. Dysfunction of retinal neurons and glia during diabetes. Clin Exp Optom 2005;3:132-145.
6. Martin PM, Roon P, Van Ells TK, et al. Death of retinal neurons in streptozocininduced diabetic mice. Invest Ophthalmol Vis Sci 2004;45:3330-36.
7. lonneville YH, Ozdek SC. Onol M. et al. The effect of blood glucose regulation on retinal nerve fiber layer thickness in diabetic patients. Ophthalmologica 2003;217:347-60.
8. Oxdek S, Lonneville YH, Onol M, et al. Assessment of nerve fiber layer in diabetic patients with scanning laser polarimetry. Eye 2002;16:761-65.
9. Lopes de Farie JM, Russ H. Costa VP. Retinal nerve fiber layer loss in patients with type 1 diabetes mellitus without retinopathy. Br J Ophthalmol 2002;86(725-28.
10. Takahashl H, Goto T. Shoji T. et al. Diabetes-associated retinal nerve fiber damage evaluated with scanning laser polarimetry. Am J Ophthalmol 2006;142:88-94.
11. Shirao Y, Kawasaky K. Electrical responses from diabetic retina. Progr Retin Eye Res 1998;17:59-76.
12. Parisi V, Uccioli L. Visual electrophysiological responses in persons with type 1 diabetes. Diabetes Metab Res Rev 2001;17:12-8.
13. Hancock HA, Kraft TW. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest Ophthalmol Vis Sci 2004;45:1002- 8.
14. Verrotti A, Lobefalo L, Petitti MT, et al. Relationship between contrast sensitivity and metabolic control in diabetics with and without retinopathy. Ann Med 1998;30:369-74.
15. Greenstein VC, Shapiro A, Zaidi Q. et al. Psychophysical evidence for post-receptoral sensitivity loss in diabetics. Invest Ohthalmol Vis Sci 1992;33:2781-90.
16. Greenstein VC, Thomas SR, Blaustein H, et al. Effects of early diabetic retinopathy on rod system sensitivity. Optom Vis Sci 1993;70:18-23.
17. Nomura R, Terasaki H, Hirose H, et al. Blue-on-yellow perimetry to evaluate S cone sensitivity in diabetics. Ophthalmic Res 2000;32:69-72.
18. Remky A, Weber A, Hendricks S, et al. Short-wavelength automated perimetry in patients with diabetes mellitus without macular edema. Graefes Arch Clin Exp Ophthalmol 2003;241:468-71.
19. Parikh R, Naik M, Mathai A, et al. Role of frequency doubling technology perimetry in screening of diabetic retinopathy. Indian J Ophthalmol 2006;54:17-22.
20. Johnson CA, Cioffi GA. Van Buskirk EM. Frequency doubling technology perimetry using 24-2 stimulus presentation pattern. Optom Vis Sci 1999;76:571-81.
21. Zhang L, Krzentowsky G, Albert A, et al. Risk of developing retinopathy in diabetes control and complications trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 2001;24:1275-79.
22. Spry PGD, Hussin HM, Sparrow JM. Clinical evaluation of frequency doubling technology perimetry using the Humphrey Matrix 24-2 threshold strategy. Br J Ophthalmol 2005;89:1031-35.
23. Anderson DR, Patella VM. Automated Static Perimetry. Mosby, Inc.. 1999.
24. Zhou Q, Weinreb RN. Individualized compensation of anterior segment birefringence during scanning laser polarimetry. Invest Ophthalmol Vis Sci 2002;43:2221-28.
25. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsycopharmacol Biol Psychiatry 2003;27:283-90.